sabarubicin has been researched along with amrubicin in 1 studies
| Studies (sabarubicin) | Trials (sabarubicin) | Recent Studies (post-2010) (sabarubicin) | Studies (amrubicin) | Trials (amrubicin) | Recent Studies (post-2010) (amrubicin) |
|---|---|---|---|---|---|
| 29 | 5 | 4 | 230 | 76 | 112 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belevich, YV; Dygai, AM; Goldberg, AV; Goldberg, VE; Miroshnichenko, LA; Polyakova, TY; Popova, NO; Simanina, EV; Simolina, EI; Tuzikova, TP; Udut, EV; Vysotskaya, VV; Zhdanov, VV; Zyuz'kov, GN | 1 |
1 other study(ies) available for sabarubicin and amrubicin
| Article | Year |
|---|---|
Assessment of Erythroid and Granulocytic Hematopoietic Lineages in Patients with Non-Small-Cell Lung Carcinoma.
Topics: Anthracyclines; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cisplatin; Disaccharides; Docetaxel; Doxorubicin; Erythropoiesis; Granulocytes; Hematopoietic Stem Cells; Humans; Lung Neoplasms; Macrolides; Nitrosourea Compounds; Organoplatinum Compounds; Taxoids | 2017 |